Your browser doesn't support javascript.
loading
Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein.
Greinacher, Andreas; Selleng, Kathleen; Mayerle, Julia; Palankar, Raghavendra; Wesche, Jan; Reiche, Sven; Aebischer, Andrea; Warkentin, Theodore E; Muenchhoff, Maximilian; Hellmuth, Johannes C; Keppler, Oliver T; Duerschmied, Daniel; Lother, Achim; Rieg, Siegbert; Gawaz, Meinrad Paul; Mueller, Karin Anne Lydia; Scheer, Christian S; Napp, Matthias; Hahnenkamp, Klaus; Lucchese, Guglielmo; Vogelgesang, Antje; Flöel, Agnes; Lovreglio, Piero; Stufano, Angela; Marschalek, Rolf; Thiele, Thomas.
Afiliación
  • Greinacher A; Institute of Immunology and Transfusion Medicine, Department of Transfusion Medicine, Universitätsmedizin Greifswald, Greifswald, Germany.
  • Selleng K; Institute of Immunology and Transfusion Medicine, Department of Transfusion Medicine, Universitätsmedizin Greifswald, Greifswald, Germany.
  • Mayerle J; Department of Medicine II, University Hospital Munich, and German Centre for Infection Research (DZIF) (partner site Munich), Munich, Germany.
  • Palankar R; Institute of Immunology and Transfusion Medicine, Department of Transfusion Medicine, Universitätsmedizin Greifswald, Greifswald, Germany.
  • Wesche J; Institute of Immunology and Transfusion Medicine, Department of Transfusion Medicine, Universitätsmedizin Greifswald, Greifswald, Germany.
  • Reiche S; Department of Experimental Animal Facilities and Biorisk Management, Friedrich-Loeffler Institut, Greifswald, Germany.
  • Aebischer A; Department of Experimental Animal Facilities and Biorisk Management, Friedrich-Loeffler Institut, Greifswald, Germany.
  • Warkentin TE; Department of Pathology and Molecular Medicine, and Department of Medicine, McMaster University, Hamilton, ON, Canada.
  • Muenchhoff M; Max von Pettenkofer Institute, Virology, Ludwig Maximilians University of Munich, and DZIF, Munich, Germany.
  • Hellmuth JC; Department of Medicine III, University Hospital Munich, Munich, Germany.
  • Keppler OT; Max von Pettenkofer Institute, Virology, Ludwig Maximilians University of Munich, and DZIF, Munich, Germany.
  • Duerschmied D; Heart Center Freiburg University, Cardiology and Angiology I and Medical Intensive Care, Medical Center.
  • Lother A; Heart Center Freiburg University, Cardiology and Angiology I and Medical Intensive Care, Medical Center.
  • Rieg S; Institute of Experimental and Clinical Pharmacology and Toxicology, and.
  • Gawaz MP; Division of Infectious Diseases, Department of Medicine II, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany.
  • Mueller KAL; Department of Cardiology and Angiology, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany.
  • Scheer CS; Department of Cardiology and Angiology, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany.
  • Napp M; Department of Anesthesiology and Intensive Care Medicine, and.
  • Hahnenkamp K; Department of Anesthesiology and Intensive Care Medicine, and.
  • Lucchese G; Department of Anesthesiology and Intensive Care Medicine, and.
  • Vogelgesang A; Department of Neurology, University Medicine Greifswald, Greifswald, Germany.
  • Flöel A; Department of Neurology, University Medicine Greifswald, Greifswald, Germany.
  • Lovreglio P; Department of Neurology, University Medicine Greifswald, Greifswald, Germany.
  • Stufano A; Interdisciplinary Department of Medicine, University of Bari Aldo Moro, Bari, Italy; and.
  • Marschalek R; Interdisciplinary Department of Medicine, University of Bari Aldo Moro, Bari, Italy; and.
  • Thiele T; Institute of Pharmacology Biology, Biocenter, Goethe University, Frankfurt am Main, Germany.
Blood ; 138(14): 1269-1277, 2021 10 07.
Article en En | MEDLINE | ID: mdl-34280256
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Factor Plaquetario 4 / Púrpura Trombocitopénica Idiopática / Reacciones Cruzadas / Glicoproteína de la Espiga del Coronavirus / Vacunas contra la COVID-19 / Anticuerpos Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2021 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Factor Plaquetario 4 / Púrpura Trombocitopénica Idiopática / Reacciones Cruzadas / Glicoproteína de la Espiga del Coronavirus / Vacunas contra la COVID-19 / Anticuerpos Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2021 Tipo del documento: Article País de afiliación: Alemania